|
||||
| Wednesday, October 24, 2007: 7:00 AM-8:30 AM | |||
| Grand Station III, IV, V (Sheraton Station Square Hotel) | |||
| Poster Session IV | |||
| P4-1 | PATIENT-SPECIFIC DECISION MAKING FOR WARFARIN THERAPY IN NONVALVULAR ATRIAL FIBRILLATION: HOW WILL SCREENING WITH GENETICS AND IMAGING HELP? Mark H. Eckman, MD, MS, Steven M. Greenberg, MD, PhD, Lawrence K.S. Wong, MD, Yannie O.Y. Soo, MD, Wynnie W. M. Lam, MD, Song Ran Yang, MD, Jonathan Rosand, MD, MSc | ||
| P4-2 | COST COMPARISONS BETWEEN HOME- AND CLINIC-BASED TESTING FOR SEXUALLY TRANSMITTED DISEASES IN HIGH-RISK YOUNG WOMEN Kenneth J. Smith, MD, MS, Robert L. Cook, MD, MPH, Roberta B. Ness, MD, MPH | ||
| P4-3 | HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC GOUT Dinesh Khanna, MD, MS, Mansoor Ahmed, MD, Dustin Yontz, Shaari Ginsburg, Grace Park, Joel Tsevat, MD, MPH | ||
| P4-4 | WHAT LIMITATIONS DOES A SYSTEMATIC REVIEW OF TRIPTANS FOR ACUTE MIGRAINE POSE FOR DECISION MAKING? Lynda McGahan, MSc, Stephen Membe, BA, (HON), MDE, Karen Cimon, MLT, Monika Mierzwinski-Urban, BA, MLIS | ||
| P4-5 | COST AND EFFECTIVENESS OF HIV SCREENING IN THREE HEALTH CARE SETTINGS Angela Hutchinson, PhD, MPH, Paul Farnham, PhD, Stephanie Sansom, PhD, Bernard Branson, MD | ||
| P4-6 | HEALTH CARE UTILIZATION FOLLOWING LUNG CANCER SCREENING Margaret M. Byrne, PhD, Joel Weissfeld, PhD, Mark S. Roberts, MD, MPP | ||
| P4-7 | WHAT I SAID ISN'T WHAT I DID: THE INCONSISTENCY BETWEEN POST-DECISION AID INTENTIONS AND ACTUAL BEHAVIORS Angela Fagerlin, PhD, Brian J. Zikmund-Fisher, PhD, Dylan Smith, PhD, Holly A. Derry, MPH, Jennifer B. McClure, PhD, Sarah M. Greene, MPH, Sharon Hensley Alford, MA, Peter A. Ubel, MD | ||
| P4-8 | JUDGING BENEFITS OF RISK REDUCING DRUG THERAPIES BY NUMBER NEEDED TO TREAT OR POSTPONEMENT OF ADVERSE EVENTS: A RANDOMIZED PILOT SURVEY OF MEDICAL DOCTORS Peder A. Halvorsen, MD, Dorte Gyrd-Hansen, PhD, Jorgen Nexoe, PhD, Ivar S.ønbø Kristiansen, PhD | ||
| P4-9 | COST OF CIPROFLOXACIN/DEXAMETHASONE VERSUS AMOXICILLIN/CLAVULANIC ACID FOR TREATMENT OF ACUTE OTITIS MEDIA IN TYMPANOSTOMY TUBE PATIENTS Jordana Schmier, MA, Curtis Waycaster, PhD, Michael Wall, PhD | ||
| P4-10 | A SIMULATION OPTIMIZATION MODEL FOR DETERMINING THE OPTIMAL LOCATIONS TO SCHEDULE OUTPATIENT SPECIALTY VISITS WITHIN A FULLY DEFINED CATCHMENT AREA BY MINIMIZING PATIENT TRAVEL DISTANCE AND TIME Nan Kong, PhD, Peter Fabri, MD, PhD | ||
| P4-11 | ADVERSE SELECTION OF A CONSUMER-DIRECTED HEALTH PLAN IN A LARGE EMPLOYER DIABETES POPULATION Michael B. Nichol, PhD, Joanne Wu, MS, Tara K. Knight, PhD, Thomas Parry, PhD, Dennis H. Honda | ||
| P4-12 | QUALITY OF LIFE OF EVACUEES ONE YEAR AFTER HURRICANE KATRINA Scott LaJoie, PhD, MSPH, Ginny Sprang, PhD | ||
| P4-13 | USING MICROSIMULATION MODELING TO CAPTURE HETEROGENEITY IN LIFETIME ILLICIT DRUG USE Tanya G.K. Bentley, PhD, Jonathan P. Caulkins, PhD, Rosalie L. Pacula, PhD, Susan M. Paddock, PhD, Jeanne S. Ringel, PhD | ||
| P4-14 | WHEN PULLING YOURSELF UP BY YOUR BOOTSTRAPS LEADS YOU IN THE WRONG DIRECTION: AN ILLUSTRATION OF WHY BIAS CORRECTION USING THE BOOTSTRAP CAN MAKE AN ESTIMATE OF THE INCREMENTAL COST-EFFECTIVENESS RATIO WORSE Jeffrey Hoch, PhD | ||
| P4-15 | WOULD PHYSICIANS LIMIT THE ACCESS TO LIVER TRANSPLANTION FOR PATIENTS WITH EXCESSIVE ALCOHOL CONSUMPTION? Valerie Perut, MD, Filomena Conti, MD, PhD, Phillipe Podevin, MD, Olivier Soubrane, MD, PhD, Yvon Calmus, Gwenaelle Vidal-Trecan, MD, PhD | ||
| P4-16 | EFFECT OF CIRCUMCISION ON U.S. MALES' EXPECTED LIFETIME COST OF HIV Stephanie Sansom, PhD, Angela Hutchinson, PhD, MPH, Q An, I Hall, A Lasry, A Taylor | ||
| P4-17 | A TEST OF THE PRECISION OF PREFERENCE DATA OBTAINED USING THE STANDARD GAMBLE Ken Stein, MB, ChB, MSc, FF, Ruairidh Milne, BA, MB, ChB, MSc, Tania Crabb, Matthew Dyer, Julie Ratcliffe, PhD, John Brazier | ||
| P4-18 | RISK PREFERENCES, RISK (MIS)PERCEPTIONS AND RACIAL TREATMENT DISPARITIES Carol K. Stockman, PhD, Mark S. Roberts, MD, MPP | ||
| P4-19 | COSTS AND EFFECTIVENESS OF VOLUNTARY HIV COUNSELING AND RAPID TESTING AT A COMMUNITY CLINIC V. A MOBILE VAN IN KANSAS CITY, MISSOURI Ram K. Shrestha, PhD, Hollie A. Clark, MPH, Stephanie Sansom, PhD, Binwei Song, MS, Holly Buckendahl, MSW, Angela Hutchinson, PhD, MPH, James Heffelfinger, MD, MPH | ||
| P4-20 | LATINA PATIENT PERSPECTIVES ON INFORMED SURGICAL TREATMENT DECISION MAKING FOR BREAST CANCER Sarah T. Hawley, PhD, MPH, Nancy Janz, PhD, Ann Hamilton, PhD, Jennifer Griggs, MD, Steven Katz, MD | ||
| P4-21 | RATIONALITY IN ADOLESCENT SEXUAL DECISION-MAKING: TEEN UNDERSTANDING OF SEXUALLY TRANSMITTED INFECTION RISK AND USE OF RISK REDUCTION TECHNIQUES Zachary C. Burns, BA, Giselle Corbie-Smith, MD, MSc, Tamera Coyne-Beasley, MD, MPH, Aletha A. Akers, MD, MPH | ||
| P4-22 | ESTIMATING SENSITIVITY AND SPECIFICITY OF A DIAGNOSTIC TEST: USING A BIVARIATE META-ANALYSIS ON INDIVIDUAL PATIENT DATA TO ADJUST FOR CORRELATED MEASUREMENTS AND HETEROGENEITY ACROSS PATIENTS Majanka H. Heijenbrok-Kal, PhD, Taye H. Hamza, MSc, Lidia Arends, PhD, MA, Francesca Pugliese, MD, Theo Stijnen, PhD, M.G. Myriam Hunink, PhD, MD | ||
| P4-23 | WHO GETS TESTED AND WHY: ADOLESCENT DECISION-MAKING REGARDING SEXUALLY TRANSMITTED INFECTION TESTING Aletha A. Akers, MD, MPH, Melanie A. Gold, DO, Giselle Corbie-Smith, MD, MSc, Tamera Coyne-Beasley, MD, MPH | ||
| P4-24 | RATIONALITY IN ADOLESCENT SEXUAL DECISION-MAKING: ADOLESCENT UNDERSTANDING OF SEXUALLY TRANSMITTED INFECTION RISK AND RISK REDUCTION STRATEGIES Zachary C. Burns, BA, Melanie A. Gold, DO, Giselle Corbie-Smith, MD, MSc, Tamera Coyne-Beasley, MD, MPH, Aletha A. Akers, MD, MPH | ||
| P4-25 | PHYSICIANS' BAYESIAN BEHAVIOR WITH ONLINE BAYESIAN COMMUNICATION Harold P. Lehmann, MD, PhD | ||
| P4-26 | DOES CLINICAL UNCERTAINTY AFFECT REFERRAL DECISIONS FOR OLDER PATIENTS WITH CHRONIC KIDNEY DISEASE? Kellie Hunter Campbell, MD, Sandy G. Smith, PhD, Joshua Hemmerich, PhD, Greg A. Sachs, MD, William Dale, MD, PhD | ||
| P4-27 | COST-EFFECTIVENESS OF ANEURYSM TREATMENT IN ELDERLY PATIENTS WITH SUBARACHNOID HEMORRHAGE H. Koffijberg, Erik Buskens, PhD, G.J.E. Rinkel, MD | ||
| P4-28 | ESTIMATING THE IMPACT OF A PROPHYLACTIC HPV VACCINE ON CERVICAL CANCER INCIDENCE: A DEVELOPING COUNTRY MODEL J. Kathleen Tracy, PhD, Colleen Burgess, MS, Eli N. Perencevich, MD, MS, Rene A. Salinas, PhD, Holly D. Gaff, PhD | ||
| P4-29 | A BAYESIAN ANALYSIS FOR EVALUATION OF A SURROGATE ENDPOINT Håvard Andre Larsen, MSc., Tron Anders Moger, PhD., Ivar Sønbø Kristiansen, MD, Mph, PhD. | ||
| P4-30 | PLACEBO EFFECTS AND THE ROLE OF COMPLIANCE IN CLINICAL TRIALS William Grant, PhD | ||
| P4-31 | INTERPRETING THE EXPECTED VALUE OF PERFECT INFORMATION ABOUT PARAMETERS Susan Griffin, MSc, BSc, Karl Claxton, PhD, MSc, BA | ||
| P4-32 | AN APPLICATION OF A BIVARIATE RANDOM EFFECTS META-ANALYSIS IN A COST-EFFECTIVENESS ANALYSIS OF TREATMENT FOR SLEEP APNOEA Susan Griffin, MSc, BSc, Neil Hawkins, PhD | ||
| P4-33 | PREDICTORS OF DIAGNOSTIC ACCURACY AND PATIENT MANAGEMENT IN DIFFICULT DIAGNOSTIC PROBLEMS IN FAMILY MEDICINE Olga Kostopoulou, PhD, MSc, Clare Harries, PhD, BA, Brendan C. Delaney, MD, Jurriaan Oudhoff, PhD, MSc, M. Radhika Nath, Ph.D., Craig W. Munro, M.B.Ch.B. | ||
| P4-34 | BAYESIAN META-REGRESSION SURVIVAL MODEL WITH TIME-DEPENDENT COVARIATES TO COMPARE EFFICACY OF VARIOUS REGIMENS OF RFVIIA AND APCC IN HEMOPHILIACS WITH INHIBITORS M. J. Treur, MSc, B. M. S. Heeg, Msc, F. McCracken, MSc, A. V. Joshi, PhD, M. Botteman, Msc, F. de Charro, PhD, B. van Hout, PhD | ||
| P4-35 | A SIMPLE DECISION ANALYTIC METHOD DEMONSTRATES THE VALUE OF A MULTIVARIABLE MODEL TO DETERMINE ELIGIBILITY FOR CHEMOTHERAPY AFTER BLADDER CANCER SURGERY Andrew Vickers, PhD, Angel Serio, MS, Bernard Bochner, MD | ||
| P4-36 | INEVITABLE TRADEOFFS IN CERVICAL CANCER PREVENTION: CONSIDERATION OF BENEFITS AND RISKS TO U.S. WOMEN Natasha K. Stout, Ph.D., Jeremy D. Goldhaber-Fiebert, AB, Jesse Ortendahl, BS, Sue J. Goldie, MD, MPH | ||
| P4-37 | DECISION-MAKING WITH INSUFFICIENT DATA: THE CASE OF NVAF Liana Fraenkel, MD, MPH, Joanne Foody, MD, Terri Fried, MD | ||
| P4-38 | EFFECTS OF TAILORED AND PERSONALIZED COMMUNICATIONS IN A HYPOTHETICAL DECISION AID Amanda J. Dillard, PhD, Peter A. Ubel, MD, Brian J. Zikmund-Fisher, PhD, Rosemarie K. Pitsch, MPH, Angela Fagerlin, PhD | ||
| P4-40 | TEMPORAL ANALYSIS TO UNDERSTAND DETERMINANTS OF COMPLIANCE, READMISSION TO HOSPITAL AND DEATH IN HF PATIENTS Jeonghoon Ahn, Ph.D., Femida Gwadry-Sridhar, BSc, Pharm, MSc, Michael B. Nichol, PhD | ||
| P4-41 | DIABETIC RETINOPATHY PROGRESSION IN TYPE 2 DIABETICS: A MULTI-PARAMETER EVIDENCE SYNTHESIS Ba Pham, MSc, Stephanie A. Duench, PhD, (Candidate), John Gonder, MD, Irene Hramiak, MD, Maggie Hong Chen, MMath, Brenda Lee, MSc, Minh Do, PhD, (Candidate), Andrea Anonychuk, MSc, George Tomlinson, PhD | ||
| P4-42 | OPTIMIZING AMBULANCE DISPATCHING IN MASS CASUALTY EVENTS: A MIXED-INTEGER PROGRAMMING MODEL Eric B. Hollingsworth, BS, Wei Xiong, PhD, Gabriel Tavares, Alkis Vazacopoulos, PhD, Nathaniel Hupert, MD, MPH | ||
| P4-43 | OPTIMIZING AMBULANCE DISPATCHING IN MASS CASUALTY EVENTS: A MIXED INTEGER PROGRAMMING APPROACH Eric B. Hollingsworth, BS, Wei Xiong, PhD, Gabriel Tavares, MS, Alkis Vazacopoulos, PhD, Nathaniel Hupert, MD, MPH | ||
| P4-44 | COST UTILITY OF CELECOXIB USE IN DIFFERENT TREATMENT REGIMENS: A CANADIAN HEALTHCARE PERSPECTIVE Catherine Rousseau, M.Sc., Gergana Zlateva, PhD | ||
| P4-45 | THE COST-EFFECTIVENESS OF A NEURAL TUBE DEFECT RECURRENCE PREVENTION PROGRAM IN SOUTH CAROLINA Scott D. Grosse, PhD, Lijing Ouyang, PhD, Julianne Collins, PhD, Denise Grosse, Jane Dean, Roger Stevenson | ||
| P4-46 | PERFORMANCE OF RISK PREDICTION MODELS FOR TYPE 2 DIABETES PATIENTS Nilay D. Shah, PhD, Brian T. Denton, PhD, Amy Wagie, BS, Jason Egginton, MPH, Murat Kurt, MS, Steven A. Smith, MD | ||
| P4-47 | DIFFERENCES BETWEEN EXPERIENCED AND INEXPERIENCED WOMEN IN FACTORS TAKEN INTO CONSIDERATION WHEN FACED WITH DCIS TREATMENT DECISIONS Melony E. Sorbero, PhD, MS, MPH, Andrew W. Dick, PhD, Suzanne Heininger, RN, James Hayman, MD, Jennifer Griggs, MD | ||
| P4-48 | DYNAMIC MARKOV STATE CYCLE DIAGRAMS Ahmed M. Bayoumi, MD, MSc | ||
| P4-49 | DYNAMIC SENSITIVITY AND SPECIFICITY IN CLINICAL DIAGNOSIS Robert M. Hamm, PhD | ||
See more of The 29th Annual Meeting of the Society for Medical Decision Making (October 20-24, 2007)
Papers submitted for the Lee B. Lusted Student Prize Competition are denoted with an asterisk (*)